Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: A randomised, placebocontrolled trial

Lancet

Volumn 357, Issue 9267, 2001, Pages 1471-1477

  Schellenberg, David ^a,c   Menendez, Clara ^a   Kahigwa, Elizeus ^b   Aponte, John ^a   Vidal, Josep ^a   Tanner, Marcel ^d   Mshinda, Hassan ^c   Alonso, Pedro ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d and Children   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; FANSIDAR; MEASLES VACCINE; PLACEBO;

ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG TOLERABILITY; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; INFECTION RATE; IRON THERAPY; MALARIA; MORBIDITY; NORMAL HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TANZANIA; TREATMENT OUTCOME; VACCINATION; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 0035849308     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04643-2     Document Type: Article

References (21)

1. Schellenberg D, Menendez C, Kahigwa E, et al. African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to hospital and risk factors for death. Am J Trop Med Hyg 1999; 61: 431-38.
2. Bradley-Moore AK, Greenwood B, Bradley DJ. Malaria chemoprophylaxis with chloroquine in young Nigerian children. Ann Trop Med Parasitol 1985; 79: 563-73.
3. Greenwood BM, Greenwood AM, Bradley AK, et al. Comparison of two strategies for control of malaria within a primary health care programme in The Gambia. Lancet 1988; 1: 1121-27.
4. Alonso PL, Lindsay SW, Armstrong JR, et al. The effect of insecticide-treated bed nets on mortality of Gambian children. Lancet 1991; 337: 1499-502.
5. Menon A, Snow RW, Byass P, Greenwood BM. Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers. Trans R Soc Trop Med Hyg 1990; 84: 768-72.
6. Colbourne MJ. The effect of malaria suppression in a group of Accra school children. Trans R Soc Trop Med Hyg 1 955; 49: 357-69.
7. Laing AB. The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon, and Senegal. Bull World Health Organ 1984; 62 (suppl): 41-48.
8. Pringle G, Avery-Jones S. Observations on the early course of untreated Falciparum malaria in semi-immune African children following a short period of protection. Bull World Health Organ 1966; 34: 269-72.
9. Menendez C, Kahigwa E, Hirt R, et al. Randomised placebocontrolled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997; 350: 844-49.
10. Greenwood BM, David PH, Otoo-Forbes LN, et al. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg 1 995; 89: 629-33.
11. Hogh B, Thompson R, Lobo V, et al. The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique. Acta Trop 1994; 57: 265-77.
12. Armstrong Schellenberg JRM, Mukasa O, Abdulla S, et al. The Ifakara Demographic Surveillance System. In: INDEPTH, ed. INDEPTH Monograph Series: Demographic surveillance systems for assessing populations and their health in developing countries, vol 1 : population, health and survival in INDEPTH sites. Ottawa: IDRC/CRDI, 2001.
13. United Republic of Tanzania MoH. National guidelines for malaria diagnosis and treatment. Malaria Control Series 1. Dares Salaam: Ministry of Health, 2000.
14. Alonso PL, Smith T, Schellenberg JR, et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1 994; 344: 1175-8 1.
15. Smith T, Armstrong-Schellenberg J, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 1994; 13: 2345-58.
16. WHO, CDC. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94 (suppl 1): 1-90.
17. Ministry of Health. National guidelines for diagnosis, treatment and prevention of malaria for health workers. Nairobi: Government of Kenya, 1998.
18. Acosta CJ, Galindo CM, Schellenberg D, et al. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania. Trop Med Int Health 1999; 4: 368-76.
19. Greenwood AM, Greenwood BM, Bradley DJ, Ball P, Giles H. Enhancement of immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chloroquine. Ann Trop Med Parasitai 1981; 75: 261-63.
20. Pappaioanou M, Fishbein D, Dreesen D. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. N Engl J Med 1986; 314: 280-84.
21. Kollaritsch H, Que JJ, Kunz C, Wiedrmann G, Herzog C, Cryz SJJ. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine or yellow fever vaccine. J Infect Dis 1997; 175: 871-75.